Use of caprylic acid precipitation for protein purification

Patent metadata

Field	Value
Publication number	US-10738078-B2
Application number	US-201515523632-A
Country	US
Kind code	B2
Filing date	Nov 3, 2015
Priority date	Nov 3, 2014
Publication date	Aug 11, 2020
Grant date	Aug 11, 2020

Abstract

In certain embodiments, the invention provides a method of purifying a protein of interest from a mixture which comprises the protein of interest and one or more contaminants, comprising: a) subjecting the mixture to a first chromatography step; b) recovering the protein of interest in an elution solution; c) adding caprylic acid to the elution solution to form a contaminant precipitate; d) removing the contaminant precipitate from the elution solution; and e) subjecting the post-precipitated elution solution to a second chromatography column, thereby purifying the protein of interest.

First claim

We claim:

1. A method of purifying a protein of interest from a mixture which comprises the protein of interest and one or more contaminants, comprising:
a) subjecting the mixture to a first chromatography step, wherein the first chromatography is a protein A affinity chromatography;
b) recovering the protein of interest in an elution solution having a low pH between 2.5 and 4;
c) adding caprylic acid to the elution solution and then adjusting the pH to at least 5.5 to form a contaminant precipitate, wherein the final concentration of the caprylic acid is between about 0.5 and 1% (v/v);
d) removing the contaminant precipitate from the elution solution; and
e) subjecting the post-precipitated elution solution to a second chromatography column, wherein the second chromatography is an ion exchange chromatography, thereby purifying the protein of interest.

2. The method of claim 1 , wherein the contaminants are selected from host cell proteins, host cell metabolites, host cell constitutive proteins, nucleic acids, endotoxins, viruses, product related contaminants, lipids, media additives and media derivatives.

3. The method of claim 1 , wherein the second chromatography is a cation exchange chromatography.

4. The method of claim 1 , wherein the second chromatography is an anion exchange chromatography.

5. The method of claim 1 , wherein the contaminant precipitate is removed by centrifugation, sterile filtration, depth filtration or tangential flow filtration.

6. The method of claim 1 , wherein the final concentration of the caprylic acid is about 0.5%, 0.75% or 1% (v/v).

7. The method of claim 1 , wherein the mixture is not subjected to an additional chromatography step.

8. The method of claim 1 , wherein the mixture is selected from a harvested cell culture fluid, a cell culture supernatant, and a conditioned cell culture supernatant, a cell lysate, and a clarified bulk.

9. The method of claim 8 , wherein the cell culture is a mammalian cell culture.

10. The method of claim 1 , wherein the protein of interest is an antibody.

11. The method of claim 1 , wherein the final concentration of the caprylic acid is about 0.75% (v/v) and the pH is adjusted to at least 5.5.

Assignees

• Bristol Myers Squibb Co

Inventors

• Zheng Ji
• Wang Jue

Classifications

• C07K1/36

  by a combination of two or more processes of different types · CPC title

• C07K1/18

  Ion-exchange chromatography · CPC title

• C07K1/32 Primary

  as complexes · CPC title

• C07K1/22

  Affinity chromatography or related techniques based upon selective absorption processes · CPC title

• C07K16/065

  Purification, fragmentation · CPC title